secwatch.observer — SEC 8-K summary
======================================

Issuer:     Crinetics Pharmaceuticals, Inc. (CRNX)
CIK:        0001658247
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0000950170-24-071354
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Crinetics shareholders re-elect directors, ratify auditor, approve NEO pay
--------------------------------------------------------------------------

- Dr. Camille Bedrosian elected with 50.8M votes for (77%), 14.9M withheld; Dr. Wendell Wierenga with 50.3M for (76%).
- Ratified BDO USA as independent auditor for FY 2024: 68.0M for, 0.1M against, 16.0K abstain.
- Advisory vote on named executive officer compensation approved: 64.1M for, 1.7M against, 6.0K abstain, 2.3M broker non-votes.
- Approximately 78.7M shares (86% of eligible) voted at the June 7, 2024 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658247/000095017024071354/0000950170-24-071354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658247/000095017024071354/crnx-20240607.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer